PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel dafna.yahav@gmail.com.\', \'Infectious Diseases Unit, Rabin Medical Center, Petah Tikva, Israel.\', \'Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Department of Nephrology and Hypertension, Rabin Medical Center, Petah Tikva, Israel.\', \'Clinical Microbiology Laboratory, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel.\', \'Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/bmjopen-2021-055611
?:doi
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 34635537
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all